The Virulence Index: A Metric for Quantitative Analysis of Phage Virulence
Abstract
BackgroundOne of the main challenges in developing phage therapy and manufacturing phage products is the reliable evaluation of their efficacy, performance and quality. Since phage virulence is intrinsically difficult to fully capture, researchers have turned to rapid but partially inadequate methods for its evaluation.\n\nMaterials and MethodsThe present study demonstrates a standardized, quantitative method to assess phage virulence based on three parameters: the Virulence Index (VP) - quantifying the virulence of a phage against a host, the local virulence (vi) - assessing killing potential at given MOIs, and MV50 - the MOI at which the phage achieves 50% of its maximum theoretical virulence. This was shown through comparative analysis of the virulence of phages T4, T5 and T7.\n\nResultsUnder the conditions tested, phage T7 displayed the highest virulence, followed by phage T4 and, finally, phage T5. The impact of parameters such as temperature and medium composition on virulence was shown for each phage. The use of the method to evaluate the virulence of combinations of phages - e.g. for cocktail formulation - is also shown with phages T5 and T7.\n\nConclusionsThe method presented provides a platform for high-throughput quantitative assessment of phage virulence and quality control of phage products. It can also be applied to phage screening, evaluation of phage strains, phage mutants, infection conditions and/or the susceptibility of host strains, and the formulation of phage cocktails.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Novel Metric for Quantifying the Sustainability of Phage-Mediated Bacterial Suppression
Tomoyoshi Kaneko, Daiki Tanaka, … Satoshi Tsuneda·bioRxiv·Aug 18, 2026
- Identification of viral dose and administration time in simulated phage therapy occurrences
S. Plunder, T. Helling, … L. Marongiu·bioRxiv·May 5, 2022
- Modeling the phage properties best for therapy
James J. Bull, Gurneet Kaur, Stephen M. Krone·VirusesPeer-reviewed·Feb 13, 2026
- Large-Scale Genomic Analysis of CpG-Mediated Immunogenicity in Bacteriophages and a Novel Predictive Risk Index
Lukeman Kharrat, Camilo García-Botero, … Dwayne R. Roach·bioRxiv·May 15, 2025
- Quantifying phage infectivity from characteristics of bacterial population dynamics
M. Blazanin, E. Vasen, … P. Turner·bioRxiv·Jun 29, 2023
- Comparative study on the virulence of mycobacteriophages
Ilaria Rubino, Carlos A. Guerrero-Bustamante, … Dominic Sauvageau·Journal of VirologyPeer-reviewed·May 21, 2025